How to Choose a Hair Loss Product Without Being Sold To

This page is a method rather than a recommendation. Six questions, in order, that will get you to the bottom of almost any hair-loss product page in about ten minutes — worked through on real claims, including ones from the sellers this site is paid to link to.

One: has anyone told you what is wrong yet?

This is the question the whole market is designed to skip, and it decides everything downstream. A 2026 review of hair loss written for primary-care clinicians sets out the approach: history and scalp inspection guide the diagnosis, with the differential including telogen effluvium, alopecia areata and androgenetic alopecia, and recommended laboratory tests including thyroid-stimulating hormone, a complete blood count and iron studies (JAAPA, September 2026).

Those are different conditions with different treatments, and a shampoo is not the answer to most of them. The appointment costs less than three months of serum and pays this site nothing.

Two: is this a cosmetic or a drug, in the legal sense?

The FDA states that whether a product is a cosmetic or a drug is determined by its intended use, and that a claim such as restoring hair growth establishes a product as a drug. 21 CFR 310.527, in force since 1989, treats any over-the-counter product labelled or promoted as a hair grower as a new drug requiring approval.

So the wording on the bottle is a signal, not a style choice. Thicker-looking and fuller-looking are cosmetic claims. Regrows and restores are drug claims, and a bottle making one without approval is telling you something about the company. What thickening shampoos actually do goes through the cosmetic side of that line.

Three: where is the trial, and how big was it?

"Clinically tested" is not a result. It means a test happened. Ask how many people, for how long, and with what outcome measured — and notice how often a product page cannot answer even the first of those.

The range in this aisle is enormous. The pyrithione zinc trial had 200 men over 26 weeks with hairs counted by microscopy. The best-known serum trial in the peptide category had 32 people over 60 days. Both get called clinical.

Four: was there a control group?

This is the question that does the most work, and it is why the rosemary oil trial everyone quotes cannot prove what it is said to prove. Hair counts rose in both arms of that trial over six months — but there was nobody untreated to compare against, so the rise cannot be attributed to either treatment rather than to six months passing.

A single-arm study showing improvement is a description of the passage of time in people who volunteered for a hair study. It is not evidence that a product worked, however impressive the percentage.

Five: who paid for it?

Company-funded research is not automatically bad, and plenty of it is well conducted. It is a fact about who chose the question, the comparator and the endpoint, and it should be on the page. The most-cited caffeine trial was funded by the company selling the shampoo brand, with a company employee among its authors; the most-cited peptide serum study was authored by the product's own company and the contract laboratory that ran it.

The same test applies to the numbers on a storefront. When we read Scandinavian Biolabs' site on 24 September 2026, it printed figures such as "93% reduced hair loss in 150 days" — the company's own numbers from its own testing, on a storefront that answered in euros for us, and not a peer-reviewed trial. Vegamour's shedding claims carried a visible qualifier: based on consistent use for at least 90 days, individual results may vary. DS Laboratories says clients report visibly fuller hair over three to six months, with results varying and not guaranteed. Each of those is a legitimate cosmetic claim, carefully worded, and none of them is a hair count.

Six: is the thing you are buying the thing that was tested?

The last question is the most-skipped and the one this site scores hardest. A trial of a leave-on liquid is not a trial of the shampoo with the same word on the front; a trial of a 2% shampoo is not a trial of the 1% on the supermarket shelf; a trial of four actives in one formula is not a trial of any one of them; a trial in alopecia areata is not a trial in pattern hair loss.

Every one of those mismatches is real and every one is in the grade book on the best shampoo for hair loss, graded on published evidence.

What a regulator does when nobody asks these questions

Two examples, both verifiable. In 2015 the Federal Trade Commission acted against marketers of catalase products claiming to reverse or prevent grey hair; the resulting orders prohibit those representations and require competent and reliable scientific evidence before any health-benefit claim. And in 2018 the UK Advertising Standards Authority upheld a complaint against a caffeine shampoo's hair-loss claim after finding the submitted studies included one with no control group and one that did not relate to the advertised product.

Competent and reliable scientific evidence is the standard a regulator applies. Questions three to six above are, roughly, what it means.

The shortest possible version

1. Get a diagnosis before you get a basket.
2. Treat a flaking or itchy scalp with something whose label says so, generically and cheaply.
3. If you buy anything else, buy it knowing exactly which of the six questions it fails.
4. Give it months, not weeks, and judge it in the same light, at the same hair length, or not at all.
5. Stop when the evidence stops. Deciding that nothing here is worth your money is a legitimate result of reading this site.